Patent Application
20230173267
The subject matter described herein relates generally to transdermal, transmucosal, and dental electrical drug delivery. More particularly, the subject matter disclosed herein relates to methods and systems for delivering drug particles to a target site using a wireless patch system.
Dielectrophoresis (DEP) is the movement of particles under the influence of a non-uniform electrical field. Unlike electrophoresis (EP), in which dispersed charged particles move in a uniform (direct current) electrical field, DEP does not depend on the polarity of the field or the charge of the particles. In contrast, DEP uses the gradient of the non-uniform field and the inherent dielectric properties of particles to generate electromotive forces. Since the strength of the electromotive force depends on particle and medium properties, as well as on the applied electric field frequencies, particles can be selectively manipulated. As a result, DEP has been used to manipulate, transport, separate, and sort particles in a wide array of applications, including separating cells, stretching DNA molecules, and assembling nano circuits. AC electrokinetics (ACEK) has been shown to deliver certain drugs into human teeth more effectively than diffusion. However, using electrical wires to power intraoral ACEK devices poses risks to patients.
The concept of a pharmacotherapeutic patch is not new in medicine or dentistry. Applications include DURAGESIC® (fentanyl transdermal system) patches, which contain a high concentration of potent Schedule II opioids to manage persistent, moderate to severe chronic pain. Other examples include estradiol transdermal patches to treat hot flashes and/or vaginal dryness, itching, and burning in menopausal women. Patches are also used to prevent osteoporosis and to whiten teeth. All these patches, however, rely on passive diffusion to reach their targets. The process is often slow and inefficient.
According to some embodiments, the subject matter described herein can include a method for delivering drug particles to a target site. The method can include applying a drug delivery patch to a target site. The method can further include transmitting a signal to the drug delivery patch to power the drug delivery patch by inductive coupling, thereby motivating drug particles suspended in a fluid in the drug delivery patch towards the target site.
According to some embodiments, the subject matter described herein can include a system including a drug delivery patch and a remote power unit for the drug delivery patch. The drug delivery patch includes a substrate, an electrode integrated with the substrate, and a fluid in the substrate having drug particles suspended in the fluid. The remote power unit includes and an antenna configured to drive the antenna to emit a wireless signal to the drug delivery patch to power the drug delivery patch by inductive coupling. Powering the drug delivery patch causes the electrode in the drug delivery patch to motivate the drug particles towards a target site of the drug delivery patch.
According to some embodiments, the subject matter described herein can overcome limitations of some conventional patches by using DEP and/or alternating current electrokinetic convective vortices to load and transport drugs through skin, mucosa and into teeth. Drug flow is generated directly by inducing electromechanical effects in the fluid using an integrated interdigitated electrode. In some embodiments, the driving mechanism is due to the drug particle-fluid and particle-particle interactions under DEP and AC electrokinetics. The versatile, self-contained transdermal and intraoral drug patch transports drug particles of varying molecular weight directly into biological targets; can be used with or without matrix bands; and can be remote controlled. The integrated RF circuit is embedded in a flexible plastic substrate and is wirelessly powered by inductive coupling. After activating the patch, radio wave signals transmitted by inductive coupling are then converted into output, which provide sufficient power to drive the patch to manipulate drugs via DEP and ACEO.
In some embodiments, the systems and methods described herein can treat infection, inflammation and/or pain in situ, transporting drugs directly and noninvasively through the skin, lips and into teeth and their supporting structures. By delivering antibiotics, anesthetics, and anti-inflammatory drugs directly to specific skin and oral targets, the systems and methods described herein can reduce or even eliminate systemic side-effects and risks commonly associated with oral drug delivery and may advance the science of drug delivery by: extending targeted electrochemical drug transport to many specific intraoral and external biological targets; improving efficacy of delivery; and negating many of the safety risks associated with some conventional patches.
A certain object of the presently disclosed subject matter having been stated hereinabove, which is addressed in whole or in part by the presently disclosed subject matter, other objects and advantages will become apparent to those of ordinary skill in the art after a study of the following description of the presently disclosed subject matter and in the accompanying non-limiting Figures.
The subject matter described herein will now be explained with reference to the accompanying drawings, of which:
FIGS. 18A1-18A3 and FIGS. 18B1-18B3 and
The presently disclosed subject matter will now be described more fully hereinafter with reference to the accompanying examples, in which representative embodiments are shown. The presently disclosed subject matter can, however, be embodied in different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the embodiments to those skilled in the art.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this presently described subject matter belongs. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. Following long-standing patent law convention, the terms “a” and “an” mean “one or more” when used in this application, including the claims. The term “and/or” when used to describe two or more activities, conditions, or outcomes refers to situations wherein both of the listed conditions are included or wherein only one of the two listed conditions are included.
Unless otherwise indicated, all numbers expressing quantities of ingredients, reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about”. Accordingly, unless indicated to the contrary, the numerical parameters set forth in this specification and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by the presently disclosed subject matter. Thus, the term “about”, as used herein when referring to a value or to an amount of mass, weight, time, temperature, volume, or percentage is meant to encompass variations of ±20% or ±10%, more preferably ±5%, even more preferably ±1%, and still more preferably ±0.1% from the specified amount, as such variations are appropriate to perform the disclosed method.
The term “comprising”, which is synonymous with “including,” “containing,” or “characterized by” is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. “Comprising” is a term of art used in claim language which means that the named elements are essential, but other elements can be added and still form a construct with in the scope of the claim. As used herein, the phrase “consisting of” excludes any element, step, or ingredient not specified in the claim. When the phrase “consists of” appears in a clause of the body of a claim, rather than immediately following the preamble, it limits only the element set forth in that clause; other elements are not excluded from the claim as a whole. As used herein, the phrase “consisting essentially of” limits the scope of a claim to the specified materials or steps, plus those that do not materially affect the basic and novel characteristic(s) of the claimed subject matter. With respect to the terms “comprising”, “consisting of”, and “consisting essentially of”, where one of these three terms is used herein, the presently disclosed and claimed subject matter can include the use of either of the other two terms.
Disclosed herein are patch-based methods and systems that combine AC electroosmosis (ACE) with DEP to enhance delivery of active agents into tissues. As used herein the term “ACEO” is synonymous to “ACE”, which both refer to alternating current electroosmosis, the physical phenomenon of using AC potential to move fluids through a porous medium. ACE also has significant potential for administering precisely targeted drugs or other agents through various tissues. Electroosmosis (ED) typically refers to using DC potential to moving fluids through a porous medium. As with EO, ACEO is also based on the ion migration within a nanometer layer of charges/ions at the interfaces of electrolytes and solids (double layer). This layer of charges will migrate under electric fields tangential to the interface, and because of fluid viscosity, the ion movement carries along its surrounding fluids, leading to fluid motion.
In ACEO, the charges in the double layer are induced by AC potentials, and tangential E-fields are also from the same voltage source. Therefore, the changes of polarities in charges and field directions are simultaneous and cancelled out, maintaining steady ion migration and fluid motion. By adjusting the amplitude and frequency of AC signals, a variety of directed surface flows are produced on electrodes to manipulate and transport particles. In symmetric systems (both spatial and temporal) the resulting liquid flow is alternating in direction with a zero offset. To obtain directionality asymmetry is added either in space (by electrode geometry) or in time (by applying asymmetric AC signals).
Introduction—Drug Delivery Using an Interdigitated Electrode Assembly Powered by Inductive Coupling
AC electrokinetics (ACEK) is increasingly becoming a viable method to transport drugs directly into teeth by using an alternating current electric potential. However, a major barrier to clinical use is the reliance of such appliances on electrical wires and connectors. By using inductive coupling to power diffusion cells whose functional element is an interdigitated electrode (IDE), this obstacle can potentially be overcome.
The presently disclosed subject matter demonstrates the feasibility of using a wirelessly powered, passive and miniaturized patch for enhanced drug delivery, which eliminates the need for wire attachments and concerns related to electric leakage. The IDE assembly uses inductive coupling to drive the functional elements, which provides an aspect of the presently disclosed subject matter. After characterizing the electrode and electrical design, the functionality of the patch is validated in a common dental application in which the whitening of human teeth is known to be significantly greater compared to diffusion, when 35% carbamide peroxide is delivered by a similar diffusion cell that is powered by a function generator.
The functionality of the device is validated further by eliciting ACEK behavior of other drugs in non-uniform electrical fields at various frequency ranges wirelessly. After optimizing the frequencies for particle translation under DEP or biased ACEO, the patch comprising a receiving coil, demodulation circuit and an IDE array is used to trap, manipulate, and translate latex, tetracycline, acetaminophen, benzocaine and lidocaine particles. Drug particle movements at various frequencies are captured and analyzed with light microscopy in real time.
Example Methods and Materials
The ACEK electrode patch (
A schematic overview of the operating principle, device structure and the mechanism used by the patch for ACEK drug delivery is shown in
By transmitting the AM signal from a transmitter coil, the receiving coil receives the AM signal through an inductive link. The received AM signal is demodulated by surface mount devices (a schottky diode and a capacitor). The low frequency biased AC signal required for ACEK excitation is then delivered to the IDE. The carrier and modulating signal frequency of the AM signal is determined based on the resonance frequency of the receiving circuit and the frequency range of ACEK, respectively. As shown in
The interdigitated electrode can be of variable dimensions (smaller or bigger than the one fabricated) and vary in number of electrode finger pairs. Similarly, the receiving coil can be configured with variable turns and dimensions. The receiving coil is presented here in a layout showing the coil juxtaposed and attached to the electrode using surface mounted devices, but it can also be configured such that the receiving coil is superimposed over the electrode or in any other appropriate configuration.
Pyralux 8525R (DuPont, Wilmington, Del., United States of America), a double-sided flexible copper cladded polyimide film, is used for the fabrication of the device. The fabrication steps are as follows; 1) the film is taped on a supporting wafer and cleaned with acetone and methanol first and then spin coated with AZ1518 positive photoresist. 2) Photoresist is developed for the desired pattern by exposing it under UV light through a transparency mask for 8 seconds and then developed in developer solution. 3) The exposed copper is then chemically etched in a ferric chloride solution for approximately 25 minutes to yield an alternating pattern and rinsed thoroughly under running de-ionized (DI) water for 5 minutes. 4) Steps 1-3 are repeated to yield the receiving coil on the back side of copper film. 5) Gold electroplating is done in order to coat the IDE surface with a very thin layer of gold. 6) Through holes (216 in
The front side of the dental patch can comprise surface mount devices and metalized traces to create the front side coil and IDE (
IDE and coil impedance data were acquired using a high precision impedance analyzer (Agilent 4294A, Agilent Technologies, Santa Clara, Calif., United States of America) and the data were recorded through its LAN port onto a computer using software Data Transfer V3.0 (SEKONIC, North White Plains, N.Y., United States of America). Electrochemical impedance spectroscopy (EIS) analysis, which is a well-established method for characterizing an electrolytic cell, is used to characterize the IDE. In EIS method, an electrical circuit can be developed to represent an electrochemical cell's behavior over a range of frequencies. In some embodiments, the IDE is composed of 27 fingers each with dimension of 150 μm (width)×7850 μm (length)×18 μm (thickness). In some embodiments, the spacing between fingers is 250 μm (
When the IDE is immersed in solution, the impedance between two nearby fingers can be estimated by a network of the interfacial capacitor and charge transfer resistor in the electrode/electrolyte boundary and the electrolyte resistance and capacitance in the bulk solution (
In some embodiments, the receiving coil comprises a series connection of the front and back side coil. A two-sided configuration considerably increases the inductance of the receiving coil without increasing patch dimension (
In order to study the functionality of the patch in terms of a demodulation circuit and ACEK effect, a very simple set-up was constructed which is shown in
The ACEK effect on Tetracycline, Acetaminophen, Benzocaine and Lidocaine was studied. The experiment demonstrates the response of tetracycline (antibiotic), acetaminophen (analgesic), benzocaine and lidocaine (anesthetics) particles to induced ACEK effects after applying an AC electric field to the diffusion cell at various frequencies using the set-up in the previous experiment. 250 mg tetracycline and 325 mg acetaminophen powders were dissolved in deionized water (DI water) to form 25 μg/ml and 32.5 μg/ml aqueous solutions respectively, then mixed with a Vortex Mixer (ThermoFisher Scientific, Waltham, Mass., United States of America) and filtered. 1.8 ml 2% lidocaine and 1 ml 5% benzocaine were diluted with DI water to form 36 μg/ml and 50 μg/ml solutions respectively. 5 ml of the top layers of each drug sample was then transferred to five 1 ml vials, containing particles 1-5 μm diameter that were used in the experiment. A 50 μl sample of each drug was placed in the holder on the IDE assembly (
The use of the system for dental whitening with bleaching gel applied topically or with ACEK was studied. The experiment aims to validate the effectiveness of the diffusion cell powered by inductive coupling in a common dental application that has been shown to be enhanced with a similar diffusion cell powered by a function generator. Thirty unrestored human maxillary central incisors, free of visible cracks and caries, were used for this study. After sectioning off the roots, the anatomic crowns were embedded in acrylic molds, leaving a 5 mm×7 mm treatment window exposed on the facial enamel surface (
Whitening was measured as changes between baseline and post-treatment L* values according to the CIE 1976 L*a*b* color scale relative to the standard illuminant D65 in the transmittance mode. The L* value determines the psychometric lightness from black to white. The L* values were obtained in both specular component (SCI) and specular component excluded (SCE) measuring geometries. The specular component is the reflected light from the tooth surface such that the angle of reflection equals the angle of incidence. In general, the SCE mode relates to diffuse illumination, while SCI measurements represent total illumination which includes diffuse and the specular component.
Results
The circuit model used for receiving and demodulating the AM signal is shown in
The applied voltage to the primary coil alongside the demodulated voltage waveform over the IDE, is shown in
DEP and ACEO behavior of tetracycline and acetaminophen particles was observed throughout the entire experiment, both of which is frequency dependent. An AC electrothermal (ACET) effect with low velocity was also observed for both drugs at frequency range 100 kHz to 1 MH, which eventually tapered off to zero at 5 MH. No DEP effect was observed with either drug at this frequency range or from 50 kHz to 100 kHz. Upon decreasing the applied frequency below 50 kHz, the particles started gathering along the electrode edges indicating positive DEP (pDEP). Although the velocity of flow increased as well, the trapping effect became more obvious in the frequency range 500 Hz-10 kHz. Strong ACEO was also observed at frequencies between 500 Hz to 10 kHz.
In comparison to tetracycline and acetaminophen, the visualization of benzocaine and lidocaine particles was much more tedious and rendered the observation of ACEK effects more difficult. Nonetheless, pDEP and ACEO were observed at the 500 Hz to 10 kHz frequency range, although at higher electric fields.
Discussion
The teeth in the current study were not artificially stained and whitening was measured relative to each tooth sample's natural state of intrinsic and/or extrinsic staining. Both intrinsic and extrinsic staining due to chromatogenic material incorporated into dentin and enamel affect the light-transmitting properties of teeth, resulting in a gradual darkening. Since tooth discoloration varies in etiology, appearance, localization, severity, and adherence to tooth structure, measuring whitening changes between baseline and post-treatment L* values as a function of each individual treatment area, ensures that variability in discoloration and porosity between samples is not a factor.
Carbamide peroxide whitens tooth enamel by penetrating the porosities in the rod-like crystal structure of enamel to break down stain deposits in the dentin. Since tooth whitening is a dynamic process that is dependent on diffusion of the whitening material to interact with stain molecules, better whitening by definition implies enhancement of the diffusion process. The effectiveness of the wireless device in enhancing this diffusion process is, therefore, validated by the results, which showed that whitening was increased by two-fold when the peroxide oxidizing agent was applied by ACEK in comparison to diffusion.
The functionality of the device is validated further by using the IDE patch to elicit ACEK behavior of other drugs. By imaging pDEP behavior of acetaminophen, tetracycline, benzocaine and lidocaine particles in AC electric fields induced with an IDE assembly that is powered by inductive coupling, the study confirms that DEP can be exploited wirelessly to manipulate an assortment of drug particles at appropriate frequencies ranging from 100 Hz to 10 kHz, Additionally, the study suggests that ACEO may also be exploited wirelessly. At appropriate frequencies, drug particles could be sorted by pDEP forces and dragged to the enamel surface by additional AC electromotive forces to concentrate the particles at the enamel pores. With increased opportunity for drug particles to interact with the microporous enamel surface, this may potentially promote the uptake of an assortment of drugs in a variety of other applications.
To illustrate further how appropriate frequencies for DEP behavior can be determined for a drug by its impedance spectrum, the frequency response of the conductivity of tetracycline and acetaminophen particles (
On the other hand, DEP forces are highly localized and there is a need for longer-range translation forces that can drive the particles away from the IDE array towards the intended biologic target. Since ACEO generates vortices within the fluid that act to drag pDEP trapped particles away from the electrode edges, it is likely to generate more long range particle translation. As shown in
The translation of latex particles above the plane of the electrode under a field of 10 Vpp/mm at 8 kHz was attributed to ACEO. Although it is known that ACEO is stronger as the frequency is further decreased, no effect of ACEO was observed at frequencies below 8 kHz. This is likely due to a critical frequency at which ACEO dominates. Hence, while velocity due to ACEO increases as the frequency is lowered from the point of discernible pDEP, this velocity reaches a maximum and then reduces with a further decrease in frequency. In the experiments, the maximum ACEO vortices for benzocaine and lidocaine were apparent at 1 kHz and 500 Hz, respectively. Based on applying these fields in a similar manner to all the tested drugs, it is inferred that this mechanism can be exploited to motivate other drugs of varying molecular weight and structure.
Unlike iontophoresis and electroporation (DC) electrochemical drug delivery technologies (used in a variety of settings from physical therapy to post-operative pain management), ACEK can motivate any chemical compound, including those that are difficult to polarize because of the absence of free charges, random distribution of charge or large molecular size. Moreover, these drug delivery techniques use high current intensity or long treatment times that can lead to pain and significant soft tissue damage. In extreme cases, high currents produced by the use of DC in iontophoresis can short through a patient's heart. The use of low-voltage AC signals (0.05-0.48 mA) in this ACEK-based device is a major difference which could significantly reduce these safety risks. A dental patch that can receive the required voltage signal wirelessly and activate ACEK effects from outside the mouth is an alternative solution to conventional devices.
The translation of this technology to clinical applications is significant to the dental community. By using ACEK to drive whitening agents into tooth enamel, unpleasant side-effects associated with conventional chairside bleaching treatments can be eliminated, including sore throat and gingival inflammation. Targeted peroxide delivery could eliminate unwanted swallowing of bleaching agents, while providing enhanced absorption and, in turn, better whitening. In addition to superior whitening, the benefits can include significantly reduced treatment time and controlled penetration to decrease the risks of reduction in enamel and dentin sublayer microhardness and to bond strength of resin-based materials bonded to dentin; resulting from home and in-office bleaching systems after multiple daily applications with significantly longer treatment times.
The study showed that an IDE assembly powered by inductive coupling could trap, manipulate, and translate carboxylate-modified microspheres, tetracycline, acetaminophen, benzocaine and lidocaine particles using single frequencies to induce ACEK effects wirelessly. The study also showed that the wireless patch could be effectively applied to a dental whitening application known to be enhanced by an analogous electrochemical delivery system powered by a function generator. After applying 35% carbamide peroxide to human teeth (n=15) under ACEK effects with an IDE powered by inductive coupling for 20 minutes, SCI and SCE whitening was increased by 215% and 194% respectively, compared to topical application. By manipulating drug particles with ACEK effects, the study suggests that an IDE assembly powered by inductive coupling may potentially enhance delivery of drugs of varying molecular weight and structure in other dental applications. ACEK may potentially advance drug delivery in dentistry by: extending transport of antibiotics, analgesics and anesthetics, to specific intraoral targets; bypassing first-pass metabolism and improving the efficacy and safety of drug delivery.
Introduction—Lab on a Chip
During the past decades, lab-on-a-chip (LOC) technology, which mostly deals with precise manipulation of micro/nano-scale liquid and/or biological particles, has made considerable progress in the development of micro/nano-systems for chemical, biological, and medical applications. Among various LOC devices, many are based on electrical methods, including electrophoresis (EP), electrowetting on dielectric (EWOD), and electrokinetics effects (including dielectrophoresis (DEP), AC electroosmosis (ACEO), and electrothermal effect). These electrical LOCs have found numerous applications in processes such as drug delivery, cell analysis, analytical assay, and clinical diagnostics.
In spite of their excellent functionality, their usability needs to be simplified in order to increase the acceptance of the technology for clinical and point-of-care applications. One of those hurdles to be addressed is that they usually require many wired connections to electronic instruments such as power supplies, amplifiers, function generators, etc. Moreover, in some applications where the LOC devices are needed to be implanted inside the body or for the devices working at hard-to-reach areas, it is highly desirable that the power for device operation and data communication with the outside world be done by wireless data and power transmission.
Inductive coupling has been extensively used for wireless powering of biomedical devices and their data communication with the external world. Usually, high frequency signal transmission is adopted, which is then used directly or converted to DC power on a chip. The required power of the device is inductively coupled to a RF identification reader (RF ID) and converted into a 10 V direct-current (DC) voltage. However, electrical LOCs often have specific requirements for signal waveform and AC frequency, and on-chip regeneration of low frequency signals is challenging.
The presently disclosed subject matter provides in some embodiments a compact, flexible, low voltage, and disposable wireless lab-on-a-film (LOF) device for particle assembly, fluid mixing and pumping. The LOF device, which in some embodiments is fabricated on both sides of a flexible plastic layer with overall dimension of 10×20 mm2, comprises a receiving coil (for wirelessly receiving AM signal through inductive coupling), surface mount capacitor and diode (for demodulation of AM signal and recovering low frequency AC signal) and an interdigitated electrode (IDE) array (for excitation of ACEO effect inside of the solution over IDE). The device uses inductive coupling and AM scheme to receive the required low frequency AC signal for excitation of the ACEO effect at the IDE to achieve the abovementioned functions. The IDE works with very low voltage ranges (less than 5 V) that can be wirelessly controlled.
After characterizing the electrical components (receiving cod, IDE, and resonance response of the LOF circuit model), the capability of the LOF system is studied in recovering low frequency AC signals for a range of frequencies and waveforms from the AM signal. Moreover, the frequency and waveform of modulating signals are studied for efficient operation of the device. In order to validate the functionality of the LOF, FluoSpheres™ particles diluted in DI water are loaded into a chamber over the IDE. By transmitting an appropriate AM signal to the LOF and controlling the voltage level over the IDE, different microfluidic effects of particle assembling, fluid mixing and fluid pumping are observed.
Example Design and Operation
The front and back side coils 1022, 1024 are connected in series through a via hole 1026 in the center of the coils 1022, 1024, and together form the receiving coil 1030. The outer end of the front coil 1022 is connected to the anode of the SMD schottky diode (see circuit diagram 1004). The cathode of the diode is connected to the SMD capacitor and one end of IDE 1028. The outer end of back coil 1024 is connected to the other end of IDE 1028 and the SMD capacitor on the front side through another via hole 1026 in the flexible layer 1018. The SMD devices 1020 can be located either on the front or on the back side. Here they are put on the front side for the convenience of observing microfluidic effects on the IDE 1028.
A low frequency AC signal, which is used to provide excitation of ACEO effects, is wirelessly transmitted to the disposable LOF pad 1018 through the amplitude modulation (AM) scheme. As shown in
An AM signal is defined by its carrier and modulating signals. Here, the resonance of the coil inductance and IDE capacitance is utilized to increase the transmitted voltage level on the LOF pad 1018 and consequently the strength of electric field induced by the IDE 1028. Therefore, the carrier frequency is carefully chosen to take advantage of the circuit resonance. The modulating signal will be the signal applied over the IDE 1028 to induce ACEO flow, and ACEO effect is known to be frequency-dependent. Hence, in order to achieve optimum operation for the LOF 1000, both carrier and modulating signal frequencies are optimized.
Alternating current electroosmosis (ACEO) refers to fluid motions induced by movement of surface charges at the solid-liquid interface (electrical double layer) when an AC signal is exerted on a pair of neighboring electrodes. When a low voltage symmetric AC signal is applied to the electrode, the charges/ions in the double layer are induced by a capacitive charging mechanism. The electric fields created by two symmetric electrodes exhibit mirror symmetry. Moreover, the charges in the double layer and electric fields change signs simultaneously, which is why ACEO produces two steady, counter-rotating vortices above each electrode. A schematic view of induced microflows at the electrode surface by a symmetric AC signal 1006 is shown in
When electrodes are activated by a biased AC signal (asymmetric AC signal 1008), co-ions instead of counter ions will be appear on electrodes with positive potential due to electrochemical reaction. This process of electrode charging is known as Faradaic charging. There are some important differences between Faradaic and capacitive charging which are the basis for the generation of different microfluidic flows. 1) Faradaic charging can produce charge densities orders of magnitude higher than capacitive charging. That is why the microfluidic flows generated by Faradaic charging are much stronger than capacitive charging. 2) The microfluidic flow velocity as the result of Faradaic and capacitive charging can be estimated by σ˜exp(V) and σ˜V2, respectively. Based on these equations, as the voltage increases, the flow velocity as a result of Faradaic charging is much higher than that by capacitive charging.
If a biased signal is used for the excitation of an ACEO effect (known as biased ACEO), the positive electrode (the electrode which is connected to the positive polarity of the signal source) experiences both capacitive and Faradaic charging while the negative electrode (the electrode which is connected to the negative polarity of the signal source) always experiences capacitive charging. There is a threshold voltage for positive electrode to undergo Faradaic charging. In biased ACEO, when the voltage level is lower than the threshold voltage, both positive and negative electrodes are subject to a capacitive charging mechanism. Hence, the microflows as shown in
When the voltage level is slightly higher than the threshold voltage, the positive electrode will experience both capacitive 1010 and a weak Faradaic charging 1012. As a result, the symmetry of induced charges over the electrodes is broken which leads to creation of larger vortices covering both positive and negative electrodes as shown in
An advantage of biased ACEO flow over traditional ACEO is the tunability of the microflow's direction and velocity by controlling the biased signal's amplitude. Thus far, the biased ACEO technique has been successfully used for development of LOCs for efficient fluid mixing, pumping, and particle trapping/manipulating. Moreover, flow velocity by biased ACEO is potentially higher than ACEO pumps. Hence, biased ACEO technique is a promising technique for implementation of microfluidic devices for multifunctional operations.
For the example LOF devices described in accordance with the presently disclosed subject matter, the recovered low frequency signal over the IDE is a single sided pulse signal, as shown in
Example Methods and Materials
Pyralux 8525R (DuPont, USA), a double-sided flexible copper cladded polyimide film, is used for the device prototyping and patterned by a printed circuit board (PCB) technique. The fabrication process is simple, rapid, low cost and can be performed by benchtop equipment without the need for cleanroom facilities. Representative fabrication steps are as follows: 1) The layout of the device is drawn in Microsoft Visio software on a computer and then printed by a regular laser printer onto a Toner Transfer Paper (PulsarProFX, Colorado Springs, Colorado, United States of America). The layout of the device is shown in
3) A very thin layer of copper etch-resist film (Green TRF Foil, PulsarProFX) is then folded over the copper film and laminated for 30 seconds. 4) After the second lamination, the etch-resist film is then peeled off from the copper film. Only the previously patterned areas are covered by a very thin layer of etch-resist film. 5) The copper film is then chemically etched in a ferric chloride solution (MG Chemicals, Surrey, British Columbia, Canada) for approximately 25 minutes to yield the desired pattern, then rinsed thoroughly under running de-ionized (DI) water for 5 minutes. 6) Subsequently, gold electroplating is conducted in order to coat the IDE surface with a very thin layer of gold. 6) Through holes are drilled and electroplated to make connections between the back and front side coils and between the back coil and IDE across the polyimide support layer.
7) The device is sequentially cleaned in acetone, isopropanol alcohol (IPA) and de-ionized (DI) water with ultrasound for 5 minutes each, respectively. The electrode is cleaned in RIE plasma cleaner to remove any organic residues. 8) External electronic components (e.g. SMD diode and capacitor) are soldered on. The front and back side of the fabricated device is shown in
For low frequency signal transmission experiments, an AM signal was generated by two Agilent arbitrary waveform generators (model 33220A) and applied to the transmitter coil. An Agilent mixed signal oscilloscope (model MSO6012A) was used to view and record the demodulated signals. An Agilent impedance analyzer (model 4294A) was also used to acquire coil and IDE impedance data, and subsequently, the data were recorded through its LAN port onto a computer using software Data Transfer V3.0 (SEKONIC).
In order to visualize the biased ACEO effect by the IDE, a chamber was used to hold the solution over the IDE. Carboxylate-modified microspheres with a diameter of 1 μm (flouSpheres, Molecular Probes) were suspended in DI water as a tracer, which was used as the test solution in the experiments. The movement of particles was observed by an optical microscope NIKON ECLIPSE LV100 and the images from the microscope were acquired by a digital camera (Roper Scientific) and subsequently transferred to the computer. For fluid velocity measurement, five particles located in the gap between two electrodes near the negatively biased electrode were traced and their velocities averaged.
Results and Discussion
Miniature planar coils are known to have non-negligible parasitics, including serial resistance and shunting capacitance. A lumped equivalent circuit model for the fabricated coil is shown in
The inductance of front or back side coils can be calculated as:
Where LFront and LBack are the front and back-side coil inductances in Henries, respectively. p is the coil pitch in meter, OD and ID are the outer and inner diameters of the coil in meters, respectively. In this design, LFront and LBack have the same shape and dimension, and all the parameters in (1) are identical for both coils. With p=400 μm, OD=9.8 mm and ID=4.1 mm, LFront=LBack is calculated as 0.48 μH for 8 turns. The equivalent inductance of the LOF coil (Lsec) can be calculated by the following formula, Lsec=LFront+LBack+2M, where M is the mutual inductance of the front and back coils and is measured to be 0.51 μH. Using above mentioned formula and parameters, Lsec is calculated as 1.98 μH. The coil resistance is R=ρ×(l/A), where ρ is copper resistivity, 17.1 nΩ m; and l and A are length and cross-sectional area of the metal line, respectively. With an average length of 52.8 cm (26.4 cm for each coil) and a cross-sectional area of 150 μm×18 μm, the resistance is calculated to be Rsec=3.34Ω. The parasitic capacitance comes mostly from the outer loops. The voltage drop between the outer loops on both sides is the highest, so they contribute to the parasitic capacitance the most. The parasitic capacitance can be estimated usingCparasitic=ε0εr(A/d), Where, ε0≈8.854×10−12 (F.m−1), εr=3.4, A is the overlap area of outer loop and d is the thickness of flexible layer. The parasitic capacitance is estimated to be around 8.21 pF.
The values for the elements in the coil equivalent circuit were also extracted through curve fitting of the measured impedance data with
Characterization of the IDE is performed with the IDE immersed in working fluid. When the IDE is immersed in a solution, the impedance between two nearby fingers can be approximated by a network of an interfacial capacitor and charge transfer resistor at the electrode/electrolyte boundary and resistance and capacitance in the solution bulk.
An equivalent circuit for two neighboring fingers of IDE is shown in
By the use of the impedance network in
In the simplified circuit, the output from the secondary coil is treated as the voltage source with the amplitude of k√{square root over (Lsec/Lpri)}Vpri being attenuated by the leakage inductance of Lleak=(1−k2)Lsec, where Vpri is the voltage at the transmitter coil. The Rsec and Csec are resistance and parasitic capacitance of secondary coil, respectively. For loosely coupled inductive links, the term 1−k2 in the Lleak equation can be approximated as 1. Hence, for the circuit model shown in
Due to leakage inductance, the receiving coil parasitic capacitance, and envelop detector, the circuit in
From this equation, it can be seen that the resonance frequency is determined by the characteristics of the secondary coil and passive envelop detector circuit including the IDE circuit model. If the carrier signal frequency of AM signal is set to the resonance frequency of the link calculated in the equation, the maximum output voltage can be obtained at the secondary coil,
As a side note, the measured k at separations of 2, 5 and 10 mm is 0.35, 0.13 and 0.05, respectively. Therefore, setting the resonant frequency at 8 MHz will work for k lower than 0.35. Maximal coupling is achieved when the transmitter and receiver coils are radially aligned. In a practical operation, some degree of misalignment is expected. The measured k for different separations between the primary and secondary coils and also k as a function of lateral deviation from the co-axial is measured for a 5 mm separation and the plot is provided in ESI. There was no effect on the resonant frequency.
AM Signal Transmission and Demodulation
This section illustrates the LOF's capability in recovering a low frequency AC signal from an AM signal, with different waveforms and frequencies for both carrier and modulating signals. This section also illustrates the effect of the modulating signal's waveform and frequency on excitation of biased-ACEO effects within the solution in terms of induced ACEO flow velocity. Then, the optimal signal waveform and frequency for the modulating signal will be determined.
For this study, the frequency of the modulating signal was not the focus and was arbitrarily set at 5 kHz (In the next section we will optimize this frequency). The respective demodulated waveforms over the IDE are shown in
The average of the measured particles' velocity was plotted in
In the next step, recovering a square wave of a different frequency and the effect of signal frequency on excitation of biased-ACEO effect were studied. The circuit performance was studied for 3 different pulse signals with frequencies of 1, 10 and 20 kHz.
The applied AM signals to the primary coil and their respective demodulated pulse signals over the IDE are shown in FIGS. 18A1-18A3 and FIGS. 18B1-18B3 and
The system could successfully recover low frequency pulse signals with different frequencies from the AM signal. In order to find an optimum frequency for biased-ACEO, particle velocity was studied at different frequencies of the pulse signal. The averages of tracer particle velocity at different frequencies were plotted in
According to the study carried out in this section, for excitation of the biased-ACEO effect in the LOF device, it is most efficient to use a pulse signal at 10 kHz as the modulating signal of the AM signal, which was, in turn, adopted for the remainder of the experiments.
For example, the system can be used as a biosensor, e.g., for rapid, chairside oral fluid diagnostic tests to evaluate oral fluids for disease detection, which, in turn, could facilitate improved access and health care outcomes for patients. In this regard, the system (outside the mouth) is also a tool for rapid, point-of-care tests to provide accurate measurements of clinically validated biomarkers in saliva for screening symptomatic or asymptomatic patients.
The system can be configured for using AC electrokinetic phenomena for sorting and separating out a certain species from a heterogeneous mixture in a colloidal suspension, e.g., by reversing the method used for drug delivery to cause target particles to move away from a source and towards an electrode. In this manner, saliva can be sorted and separated using inductive coupling for salivary diagnostics.
Saliva is regarded as a “mirror of the body” that generally reflects the state of a patient's overall health. A wide range of systemic diseases, such as diabetes and Sjögren's syndrome, have oral manifestations that dentists are ideally situated to monitor and treat. For biosensor applications of the systems and methods described in this specification, oral fluid provides a diagnostic medium for rapid, point-of-care testing by virtue of the response of the biomarker to a non-uniform electrical field at a particular frequency.
Some advantages of using saliva for disease diagnostics includes ease of access, noninvasive sample collection, increased acceptance by patients, and reduced risks of infectious disease transmission. Oral samples are readily accessible as whole saliva or by sampling secretions from specific glands, mucosal transudate, or gingival crevicular fluid. Sampling oral fluids, instead of blood or urine, therefore, provides a medium for detecting a range of candidate biomarkers, such as proteins, electrolytes, hormones, antibodies and DNA/RNA, as well as other substances. Ready access to oral biofluids is helpful for one-time sample collection, and when multiple or serial sampling is required for ongoing, real-time assessment of health and disease status and physiologic markers. Analytes, such as protein and nucleic acid components, which are usually present in lower concentrations in oral fluids than in blood can be monitored with this technology by identifying candidate biomarkers at the molecular level.
Analysing oral fluid using inductive coupling can be useful, for example, in locations where medical equipment may not be available. For instance, consider an army doctor on a battle field performing a rapid diagnostic test. The doctor may not have any electrical power available or electrical function generator equipment. The can use the systems and methods described above to analyse oral fluid using a disposable electrode that does not require electrical wires and connections.
For a biased-ACEO IDE device, its two electrodes have different electrode charging processes, namely capacitive charging for the negatively biased electrode and Faradaic charging for the positively biased electrode. By controlling the voltage level of the demodulated signal over the IDE, vortexes and surface flows with varying strengths can be generated to create different microfluidic phenomena. The wireless biased-ACEO LOF described in this specification is capable of producing various microfluidic phenomena based on the voltage levels at the IDE.
An application of this device is to concentrate particles over designated electrodes. This application becomes very useful for real-time detection of low abundance bioparticles. This application has also proven quite effective in the separation of active drug particles from excepients in various drug formulations used in dentistry, which in combination with other AC electrokinetic effects such as ACEO, has been shown to deliver drug particles to various target sites more effectively than diffusion. When the voltage level over the IDE exceeds the threshold voltage for Faradaic charging, co-ions are generated over the positive electrodes. At lower voltages, Faradaic charging is partially compensated by capacitive charging over the positive electrode.
Consequently, the vortexes within the solution are very weak and the particles slowly move away from the negative electrode onto the positive electrode. A conceptional view of this phenomenon is shown in
When the voltage over the IDE goes even higher (higher than 2.5 V), Faradaic charging becomes dominant at the positively biased electrode (
One common practice in measuring k is to measure the inductance of one coil when the other coil is first open-circuited (L1) and then short-circuited (Lleak). The difference between two measurements is the coil magnetization inductance, which is related to the coupling coefficient as Lmag=k2×L1. Hence, coupling coefficient can be calculated by the following, k=√{square root over (Lmag/L1)}=√{square root over ((L1−Lleak)/L1)}.
The software used for tracking and measuring particles velocity is Image-Pro 3D Suite version 6.0 (MediaCybernetic, Rockville, Md., United States of America), which is a well-known software for microPIV applications. Because ACEK flows have non-uniform streamline, the velocity of a tracer particle is highly dependent on its position relative to the electrodes. Therefore it is desirable to note the location of tracer particles when measuring ACEK flow velocity.
The space between two electrodes was an optimum location for measuring particle velocity, since the particles had almost constant velocity there. When the particles reached the edge of the electrode their velocity was increasing, which made it very difficult to accurately measure their velocity. Also, when the particles were over electrodes, they had vertical movement. It is difficult to accurately measure their velocity.
The velocity data presented in
The presently disclosed subject matter provides a wireless biased-ACEO lab-on-a-film device that has been designed and characterized for different microfluidic applications. The required low frequency AC signal for generation of biased-ACEO effect was wirelessly transmitted through an AM technique. Unlike many wireless microfluidic systems, this system works with low voltage to generate microfluidic functions, despite the inductive link being very leaky (less than 60 V). Low voltage operation is attributed to two design considerations. One is that the circuit design on the LOF produces a resonance at the output of the receiving coil for usable voltage to be extracted, and the other is the use of the ACEO effect, which typically produces strong microfluidic movement at low voltage.
It will be understood that various details of the subject matter described herein may be changed without departing from the scope of the subject matter described herein. Furthermore, the foregoing description is for the purpose of illustration only, and not for the purpose of limitation, as the subject matter described herein is defined by the claims as set forth hereinafter.
This application is a divisional of U.S. patent application Ser. No. 15/565,534, filed Oct. 10, 2017, which is a national stage application under 35 U.S.C. § 371 of International Patent Application No. PCT/US2016/031230, filed May 6, 2016, which claims the benefit of U.S. Provisional Patent Application Ser. No. 62/158,923, filed May 8, 2015, the disclosures of each of which are incorporated herein by reference in their entireties.
| Number | Date | Country | |
|---|---|---|---|
| 62158923 | May 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15565534 | Oct 2017 | US |
| Child | 17893066 | US |
